Acibadem İzmir Kent Hospital
Izmir, 35620, Turkey (Türkiye)
NCT Number: NCT07728604
This randomized controlled study aimed to evaluate the effect of digital follow-up supported patient education on immunosuppressive medication adherence and quality of life in adult liver transplant recipients. Participants in both groups received standard discharge education. The intervention group additionally received structured digital follow-up messages for 12 weeks, while the control group received standard care only. Medication adherence and quality of life were assessed before and after the intervention using validated questionnaires.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Izmir, 35620, Turkey (Türkiye)
Lifelong adherence to immunosuppressive medication is essential for preventing graft rejection and maintaining long-term graft survival after liver transplantation. However, medication non-adherence remains a common problem and may negatively affect patient outcomes and quality of life. Digital follow-up interventions may improve adherence by providing regular reminders and educational support after discharge.
This single-blind randomized controlled trial was conducted at the Liver Transplant Center of Acibadem Kent Hospital, İzmir, Türkiye. Adult liver transplant recipients who met the eligibility criteria were randomly assigned to either a digital education group or a control group. All participants received standard discharge education. In addition, participants in the intervention group received structured digital follow-up messages for 12 weeks. The control group received routine follow-up care only.
The primary outcome was immunosuppressive medication adherence, assessed using the Immunosuppressive Medication Adherence Scale (MMAS-8). The secondary outcome was quality of life, assessed using the Chronic Liver Disease Questionnaire (CLDQ 2.0). Outcomes were evaluated before the intervention and at the end of the 12-week follow-up period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants received standard discharge education followed by structured digital follow-up messages for 12 weeks to improve immunosuppressive medication adherence and quality of life.
Participants received routine discharge education and standard follow-up care. No additional digital follow-up messages or educational reminders were provided during the study period.
Time frame: Baseline and 12 weeks
Immunosuppressive medication adherence was assessed using the Immunosuppressive Medication Adherence Scale used in this study.
Time frame: Baseline and 12 weeks
Quality of life was assessed using the Chronic Liver Disease Questionnaire (CLDQ 2.0).
Cansu Yıldız
Other
Effect of Digital Follow-up Supported Patient Education on Immunosuppressive Medication Adherence and Quality of Life in Liver Transplant Recipients: A Single-Blind Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04587024
Behavior, Health Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT05854472
Anxiety Disorders, Behavior
Izmir, Turkey (Türkiye)
View Trial DetailsNCT01294020
Heart Transplantation, Intestine Transplantation
Brussels, Belgium
View Trial DetailsNCT07233083
Liver Transplantation, Neurologic Manifestations
Istanbul, Turkey (Türkiye)
View Trial Details